C4 Therapeutics, Inc.

CCCC - CIK 0001662579

Market cap-

Rank-

SEC filings516

CCCC balance sheet (annual)

The table below shows C4 Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & equivalents	$74.60M	$55.50M	$126.59M	$29.75M	$76.12M	$181.73M
Short-term investments	-	-	-	-	$233.16M	$189.96M
Receivables	$2.40M	$3.10M	$11.80M	$1.47M	$5.72M	$4.48M
Inventory	-	-	-	-	-	-
Total current assets

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.